← All IPOs

Pramodini Medicare Ltd IPO

PRAMODINI · SME · HealthcareListed
Read filingAllotmentStock listed on 19 August
Price band
₹110 to ₹118
Issue size
₹69.04 Cr
Issue price
₹118
Lot size
1,200 shares
Min. investment
₹2,83,200

2,400 shares

Listing return
+1.69%

Listed ₹120

  1. Opens

    12 Aug 2026

  2. Closes

    14 Aug 2026

  3. Allotment

    17 Aug 2026

  4. Listing

    19 Aug 2026

Subscription

About the company

Pramodini Medicare Ltd is an Indian diagnostic services company that uses technology to serve public and private hospitals, government PSUs and medical colleges in tier I, tier II and tier III cities. Its offering spans three areas: radiology (MRI, CT scans, X-ray, ultrasound with colour Doppler, mammography, Dexa scans and interventional radiology), clinical laboratory work (haematology, microbiology, immunology, pathology and biochemistry) and nuclear medicine (PET-CT, SPECT and nuclear therapy).

A 24×7 teleradiology operation runs from the registered office in Vijayawada, where the company also has a processing unit-cum-laboratory. As of December 31, 2025, it ran 15 diagnostic centres spread over six states and 13 cities, delivered through public-private partnerships, private-private partnerships, tie-ups with government PSUs and standalone private centres.

Founded2000MDDr. Chalasani Kuldeep Kumar

Objective of IPO proceeds

ParticularsEstimated amount (₹ Cr.)
Funding of capital expenditure for purchase of medical equipments towards existing and proposed diagnostic centres45.15
General corporate purposes—

Key performance indicators (KPIs)

for the year ended March 31, 2026

  • ROE39.08%
  • ROCE34.66%
  • EBITDA Margin49.61%
  • PAT Margin27.9%
  • Return on Net Worth (RoNW)32.69%

Debt/Equity Ratio

0.34

Net Asset Value (NAV) per Equity Share

31.84

EPS (Pre-IPO)

10.41

View table
KPIValue (for the year ended March 31, 2026)
ROE (%)39.08
ROCE (%)34.66
EBITDA Margin (%)49.61
Debt/Equity Ratio0.34
PAT Margin (%)27.9
Return on Net Worth (RoNW) (%)32.69
Net Asset Value (NAV) per Equity Share (₹)31.84
EPS (Pre-IPO) (₹)10.41

Financials

₹ crore

Revenue

38.24

+8.5%

Total Assets

53.27

+14.3%

Profit

11.54

+51.4%
View table
Line202320242025
Revenue30.5835.2338.24
Total Assets47.4746.5953.27
Profit5.877.6211.54

Book running lead managers & registrar

Book running lead managersSmart Horizon Capital Advisors Private Limited
Registrar to the issuePurva Sharegistry (India) Private Limited

Pramodini Medicare IPO contact details

Company namePramodini Medicare Limited
Registered officeD.No: - 29-4-54K, CSI Complex, Prakasam Road, Suryaraopet, Vijayawada, Andhra Pradesh, India – 520002
Phone+91 9985782727
Emailinvestors@pramodinidiagnostics.com
Websitewww.pramodinidiagnostics.com

Pramodini Medicare IPO registrar contact details

Company namePurva Sharegistry (India) Private Limited
Phone022 - 49614132
Emailnewissue@purvashare.com
Websitewww.purvashare.com

Thesis

  • 1

    The network reached 15 diagnostic centres in 13 cities across six states as of December 31, 2025, covering Uttar Pradesh, Andhra Pradesh, Karnataka, West Bengal, Haryana/NCR Delhi and Kerala, though the Kerala operations were yet to start.

  • 2

    Services are delivered under four models: seven public-private partnership centres, three private-private partnerships, three strategic tie-ups with government PSUs and two standalone private centres, plus a processing unit.

  • 3

    The equipment fleet as of December 31, 2025 included seven CT and seven MRI machines, 20 X-ray units, 15 ultrasound machines, two Dexa and two mammography machines, one PET-CT, six CR systems and three DR systems.

  • 4

    Revenue comes from B2G, B2B and B2C segments; in the nine months to December 31, 2025, government business was 61.32% of revenue from operations, B2B 20.09% and B2C 18.60%.

  • 5

    Radiology and pathology both run on technology-enabled platforms, with MRI, CT, X-ray, ultrasound, Dexa and mammography on the imaging side and fully automatic analysers for routine and specialised pathology tests.

  • 6

    Both revenue from operations and PAT have grown steadily: revenue rose from Rs 30.58 crore in FY23 to Rs 35.23 crore in FY24 and Rs 38.24 crore in FY25, while PAT climbed from Rs 5.87 crore to Rs 7.62 crore and then Rs 11.54 crore over the same years.

Application details

  • Individual investor

    ₹110 - ₹118 · from ₹2,00,000 onwards.

    1,200sharesMin 2,400

Figures come from the company filing. This is not a recommendation.